US district court blocks FDA's efforts to reclassify certain medical devices as drugs
This article was originally published in Clinica
A US district court has issued a decision which legal experts say will effectively prevent the Food and Administration from implementing new product classification rules that could have resulted in numerous medical products previously classified as devices to be reclassified as drugs.
You may also be interested in...
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.